AU771256B2 - Medicaments comprising relaxin and their use - Google Patents

Medicaments comprising relaxin and their use Download PDF

Info

Publication number
AU771256B2
AU771256B2 AU54199/00A AU5419900A AU771256B2 AU 771256 B2 AU771256 B2 AU 771256B2 AU 54199/00 A AU54199/00 A AU 54199/00A AU 5419900 A AU5419900 A AU 5419900A AU 771256 B2 AU771256 B2 AU 771256B2
Authority
AU
Australia
Prior art keywords
relaxin
hair growth
acceptable carrier
pharmaceutically acceptable
androgenetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU54199/00A
Other languages
English (en)
Other versions
AU5419900A (en
Inventor
Raziel Lurie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/348,062 external-priority patent/US6075005A/en
Application filed by Individual filed Critical Individual
Publication of AU5419900A publication Critical patent/AU5419900A/en
Application granted granted Critical
Publication of AU771256B2 publication Critical patent/AU771256B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU54199/00A 1999-07-06 2000-07-03 Medicaments comprising relaxin and their use Ceased AU771256B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/348,062 US6075005A (en) 1993-10-03 1999-07-06 Medicaments comprising relaxin and their use
US09/348062 1999-07-06
PCT/IB2000/000901 WO2001001997A1 (en) 1999-07-06 2000-07-03 Medicaments comprising relaxin and their use

Publications (2)

Publication Number Publication Date
AU5419900A AU5419900A (en) 2001-01-22
AU771256B2 true AU771256B2 (en) 2004-03-18

Family

ID=23366490

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54199/00A Ceased AU771256B2 (en) 1999-07-06 2000-07-03 Medicaments comprising relaxin and their use

Country Status (4)

Country Link
EP (1) EP1154783A4 (de)
AU (1) AU771256B2 (de)
CA (1) CA2378598A1 (de)
WO (1) WO2001001997A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224780B1 (es) * 2002-02-21 2007-03-01 Adnan Ammura Taha Composicion regeneradora capilar.
US7320967B2 (en) 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
ES2576655B1 (es) * 2015-01-08 2017-04-20 Anastasio SOLANA MURILLO Tratamiento capilar compuesto de acetato de ciproterona
MX2018001546A (es) * 2018-02-06 2019-08-07 Centro Int De Cosmiatria S A P I De C V Formulacion y metodo para el tratamiento de la alopecia androgenica.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096246A (en) * 1960-05-24 1963-07-02 Warner Lambert Pharmaceutical Process for the extraction and purification of relaxin
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
FI59534C (fi) * 1979-10-31 1981-09-10 Orion Yhtymae Oy Vaordmedel foer fraemjande av haorvaext och hindrande av mjaell
US5344651A (en) * 1993-07-23 1994-09-06 The Procter & Gamble Company Cyproterone acetate thioacetate
IL107167A (en) * 1993-10-03 2000-01-31 Raziel Lurie Compositions containing relaxin for treatment of alopecia and related conditions
AU7078296A (en) * 1995-09-27 1997-04-17 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096246A (en) * 1960-05-24 1963-07-02 Warner Lambert Pharmaceutical Process for the extraction and purification of relaxin
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
AU5419900A (en) 2001-01-22
WO2001001997A1 (en) 2001-01-11
EP1154783A1 (de) 2001-11-21
CA2378598A1 (en) 2001-01-11
EP1154783A4 (de) 2005-01-19

Similar Documents

Publication Publication Date Title
US6075005A (en) Medicaments comprising relaxin and their use
Shapiro et al. Hair regrowth: therapeutic agents
US5407944A (en) Compositions and methods for promoting hair growth
US20100172865A1 (en) Methods of enhancing hair growth
US5574011A (en) Compositions and methods for the treatment of male-pattern baldness
KR101776544B1 (ko) 화장용 및 기타 용도용 ｃ-19 스테로이드
DK2500062T3 (en) C-19 steroids to specific therapeutic applications,
Gruber et al. Current concepts in aesthetic endocrinology
JPH11500145A (ja) 毛髪の成長の刺激または促進および／または脱毛を抑制するブラジキニン拮抗薬の使用
AU771256B2 (en) Medicaments comprising relaxin and their use
Faloia et al. Effect of finasteride in idiopathic hirsutism
Mor et al. Cutaneous complications of hormonal replacement therapy
SCHRIOCK et al. Treatment of hirsutism
Murray Natural progesterone: what role in women’s health care
McKenna et al. The adrenal cortex and virilization
US6395706B1 (en) Medicaments comprising relaxin and their use
JP2000505454A (ja) 脱毛症の治療方法
Tromovitch et al. Medical treatment of male pattern alopecia (androgenic alopecia)
Neumann Pharmacology and clinical use of antiandrogens: a short review
WO2014073919A1 (ko) 탈모증의 예방, 치료 또는 개선용 조성물
Steward et al. Antiandrogens and the skin.
Sagili et al. Cutaneous manifestations of estrogen excess and deficiency
HRP20040914A2 (en) Pharmaceutical and cosmetic compositions comprising plgf-1
Sawaya Alopecia-the search for novel agents continues
GB2131292A (en) Progestational pharmaceutical formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 18, PAGE(S) 3825-3828 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 54199/00, 61555/00 AND 42342/01

FGA Letters patent sealed or granted (standard patent)